Updates from The Motley Fool

Latest updates on Geron Corp from Fool.com.

Stock Performance

GERN vs. S&P 500 | 2 Year Performance
GERN 1-Day Stock Chart
GERN 5-Day Stock Chart
GERN 1-Month Stock Chart
GERN 3-Month Stock Chart
GERN 6-Month Stock Chart
GERN 1-Year Stock Chart
GERN 2-Year Stock Chart
GERN 5-Year Stock Chart
View Interactive GERN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Geron Corp.
Current Price: $2.94
Prev Close: $2.92
Open: $2.93
Bid: $2.91
Ask: $2.96
Day's Range: $2.90 - $3.03
52wk Range: $2.30 - $5.30
Volume: 2,207,916
Avg Vol 1,701,460
Market Cap: $465.17M
P/E (ttm): 0.00
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Geron Corp.
CAPS Rating 3 out of 5
644 Outperform
61 Underperform
CAPS All Stars
81 Outperform
17 Underperform

How do you think Geron Corp will perform against the market?

You pick for Geron Corp is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John A. Scarlett, CEO

100% Approve

Based on 2 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Geron Corp.

A biopharmaceutical company which is developing first-in-class therapeutic products for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, diabetes and HIV/AIDS.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers